Rhythm Biosciences Ltd (ASX: RHY) Completes Genetype Acquisition
Rhythm Biosciences Ltd completes the acquisition of Genetype assets, enhancing its cancer diagnostics portfolio.
Rhythm Biosciences Ltd completes the acquisition of Genetype assets, enhancing its cancer diagnostics portfolio.
Tivan Limited confirms compliance with ASX Listing Rules following $7.4 million grant announcement.
C29 Metals Limited faces a setback as Ministerial approval for Ulytau Resources is refused, leading to a pause in exploration works.
C29 Metals Limited (ASX:C29) has had its trading reinstated following the approval of the Ulytau tenement transfer.
Mayfield Childcare Limited (ASX:MFD) has requested a trading halt pending an announcement regarding a corporate transaction.
Touch Ventures invests A$10.6m in Reshop to enhance instant refund capabilities for US consumers.
Norwest Minerals (ASX:NWM) confirms significant silver, copper, lead, and zinc intersections at Dales Gossan, with future drilling planned for 2025.
Epsilon Healthcare Limited (ASX:EPN) outlines its ambitious targets and operational capabilities, aiming for $14M revenue growth.
IRIS Metals Limited (ASX:IR1) announces final assays from Beecher Project, confirming significant lithium intersections and future production plans.
Voltaic Strategic Resources confirms high-grade gold at Kooline Project, enhancing exploration potential.